The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
Open accessAbstract
PURPOSE OF REVIEW: As a rare pediatric tumor, hepatoblastoma presents challenges to the individual practitioner as no center will see more than a handful of cases each year. RECENT FINDINGS: The Children's Hepatic tumor International Collaborative (CHIC) effort has fostered international cooperation in this rare children's tumor, leading to the establishment of a large international collaborative dataset, the CHIC database, which has been interrogated to refine risk stratification and inform treatment options. Apace with this effort has been the international collaboration of pediatric pathologists working together to establish a new international histopathologic consensus classification for pediatric liver tumors as a whole, with particular focus on the histological subtypes of hepatoblastoma. SUMMARY: International collaborative efforts in hepatoblastoma have led to a new international histopathologic consensus classification, refinements in risk stratification, advances in chemotherapy, and a better understanding of surgical resection options forming the foundation for the development of an upcoming international therapeutic trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Telomerase modulates Wnt signalling by association with target gene chromatin
Park, J.-I., Venteicher, A. S., Hong, J. Y., Choi, J., Jun, S., Shkreli, M., Chang, W., Meng, Z., Cheung, P., Ji, H., et al. (2009) · Nature · doi:10.1038/nature08137 · Cited by 707 · cited 1×
“As a result, activation of TERT and MYC signaling appears to play a role in the more aggressive phenotypes of hepatoblastoma [24,25].”
BackgroundCairo, S., Armengol, C., De Reyniès, A., Wei, Y., Thomas, E., Renard, C.-A., Goga, A., Balakrishnan, A., Semeraro, M., Gresh, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.002 · Cited by 509
Primary hepatic tumors of childhood
Weinberg, A. G., & Finegold, M. J. (1983) · Human Pathology · doi:10.1016/s0046-8177(83)80005-7 · Cited by 509
Zsiros, J., Brugieres, L., Brock, P., Roebuck, D., Maibach, R., Zimmermann, A., Childs, M., Pariente, D., Laithier, V., Otte, J.-B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70272-9 · Cited by 345
Self-citationThe epidemiology of hepatoblastoma
Spector, L. G., & Birch, J. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24215 · Cited by 328
Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
Perilongo, G., Maibach, R., Shafford, E., Brugieres, L., Brock, P., Morland, B., de Camargo, B., Zsiros, J., Roebuck, D., Zimmermann, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810613 · Cited by 320
Self-citationPritchard, J., Brown, J., Shafford, E., Perilongo, G., Brock, P., Dicks-Mireaux, C., Keeling, J., Phillips, A., Vos, A., & Plaschkes, J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3819 · Cited by 269
Fuchs, J., Rydzynski, J., von Schweinitz, D., Bode, U., Hecker, H., Weinel, P., Bürger, D., Harms, D., Erttmann, R., Oldhafer, K. J., et al. (2002) · Cancer · doi:10.1002/cncr.10632 · Cited by 265
Aronson, D. C., Schnater, J. M., Staalman, C. R., Weverling, G. J., Plaschkes, J., Perilongo, G., Brown, J., Phillips, A., Otte, J.-B., Czauderna, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.145 · Cited by 218
Self-citationClinical utility of telomerase in cancer
Hiyama, E., & Hiyama, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205070 · Cited by 202
Self-citationBeckwith-Wiedemann Syndrome: Historical, Clinicopathological, and Etiopathogenetic Perspectives
Cohen, M. M. (2005) · Pediatric and Developmental Pathology · doi:10.1007/s10024-005-1154-9 · Cited by 196
Trobaugh‐Lotrario, A. D., Tomlinson, G. E., Finegold, M. J., Gore, L., & Feusner, J. H. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21834 · Cited by 171
Hiyama, E., Hiyama, K., Yokoyama, T., & Shay, J. W. (2001) · Neoplasia · doi:10.1038/sj.neo.7900134 · Cited by 162
Self-citationWnt signaling and hepatocarcinogenesis: The hepatoblastoma model
Armengol, C., Cairo, S., Fabrè, M., & Buendia, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.012 · Cited by 147
Takayasu, H., Horie, H., Hiyama, E., Matsunaga, T., Hayashi, Y., Watanabe, Y., Suita, S., Kaneko, M., Sasaki, F., Hashizume, K., et al. (2001) · PubMed · Cited by 134
Self-citationHepatoblastoma and Familial Adenomatous Polyposis
Garber, J. E., Li, F. P., Kingston, J. E., Krush, A. J., Strong, L. C., Finegold, M. J., Bertario, L., Bülow, S., Filippone, A., Gedde‐Dahl, T., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.20.1626 · Cited by 108
Activation of Phosphatidylinositol-3′-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival
Hartmann, W., Küchler, J. N., Koch, A., Friedrichs, N., Waha, A., Endl, E., Czerwitzki, J., Metzger, D., Steiner, S., Wurst, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2878 · Cited by 90
Hiyama, E., Yamaoka, H., Matsunaga, T., Hayashi, Y., Ando, H., Suita, S., Horie, H., Kaneko, M., Sasaki, F., Hashizume, K., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602054 · Cited by 64
Self-citationAltered expression of members of the IGF-axis in hepatoblastomas
Gray, S. G., Eriksson, T. M., Ekström, C., Holm, S., von Schweinitz, D., Kogner, P., Sandstedt, B., Pietsch, T., & Ekstöm, T. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1179 · Cited by 56
Familial Hepatoblastoma and APC gene mutations: renewed call for molecular research
Thomas, D., Pritchard, J., Davidson, R., McKiernan, P. J., Grundy, R. G., & de Goyet, J. D. V. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00618-x · Cited by 52
Anna, C. H., Sills, R. C., Foley, J. F., Stockton, P. S., Ton, T.-V. T., & Devereux, T. R. (2000) · PubMed · Cited by 51
Beaty, O., Berg, S. L., Blaney, S. M., Malogolowkin, M. H., Krailo, M., Knight, R., Schaiquevich, P. S., Stewart, C. F., Chen, Z., Nelson, M. D., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22544 · Cited by 50
Self-citationFinegold, M. J. (1994) · Seminars in Liver Disease · doi:10.1055/s-2007-1007317 · Cited by 46
Ueda, Y., Hiyama, E., Kamimatsuse, A., Kamei, N., Ogura, K., & Sueda, T. (2011) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.09.003 · Cited by 43
Self-citationSaito, H., Morizane, T., Watanabe, T., Kagawa, T., Iwabuchi, N., Kumagai, N., Inagaki, Y., Tsuchimoto, K., & Tsuchiya, M. (1989) · Cancer · doi:10.1002/1097-0142(19890901)64:5<1169::aid-cncr2820640534>3.0.co;2-i · Cited by 37
Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells
Lieber, J., Kirchner, B., Eicher, C., Warmann, S. W., Seitz, G., Fuchs, J., & Armeanu–Ebinger, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22740 · Cited by 35
Targets for active immunotherapy against pediatric solid tumors
Jacobs, J. F. M., Coulie, P. G., Figdor, C. G., Adema, G. J., de Vries, I. J. M., & Hoogerbrugge, P. M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0619-x · Cited by 11
Emerging gene-directed anti-tumor strategies against human hepatoblastoma
内山, 政., 奥村, 聰., 河上, 由., & 中川, 太. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903136696 · Cited by 9
Cited by
Meyers, R. L., Maibach, R., Hiyama, E., Häberle, B., Krailo, M., Rangaswami, A., Aronson, D. C., Malogolowkin, M. H., Perilongo, G., von Schweinitz, D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30598-8 · Cited by 439
Self-citationGenomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Sumazin, P., Chen, Y., Treviño, L. R., Sarabia, S. F., Hampton, O. A., Patel, K., Mistretta, T., Zorman, B., Thompson, P., Heczey, A., et al. (2017) · Hepatology · doi:10.1002/hep.28888 · Cited by 258
Self-citation
Metadata
- Authors
- Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L.
- Venue
- Current Opinion in Pediatrics
- Published
- 2014-02
- Volume
- 26
- Issue
- 1
- Pages
- 19-28
- ISSN
- 1040-8703 (ISSN-L)
- OpenAlex
- W1990938368
- Cited by
- 306
- References
- 29
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.